June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Cellular senescence promotes meibomian gland dysfunction (MGD) in a chronic graft-vs-host disease (cGVHD) mouse model
Author Affiliations & Notes
  • Shinri Sato
    Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
  • Yoko Ogawa
    Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
  • Eisuke Shimizu
    Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
  • Masatoshi Hirayama
    Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
  • Shigeto Shimmura
    Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
    Fujita Medical Innovation Center Tokyo, Fujita Ika Daigaku, Japan
  • Kazuno Negishi
    Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
  • Kazuo Tsubota
    Tsubota Laboratory, Inc., Shinjuku-ku, Tokyo, Japan
  • Footnotes
    Commercial Relationships   Shinri Sato Tsubota Laboratory, Inc., Code F (Financial Support), AMO Japan, Code F (Financial Support); Yoko Ogawa Tsubota Laboratory, Inc., Code F (Financial Support); Eisuke Shimizu Tsubota Laboratory, Inc., Code F (Financial Support); Masatoshi Hirayama None; Shigeto Shimmura None; Kazuno Negishi None; Kazuo Tsubota Tsubota Laboratory, Inc., Code E (Employment)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 691. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shinri Sato, Yoko Ogawa, Eisuke Shimizu, Masatoshi Hirayama, Shigeto Shimmura, Kazuno Negishi, Kazuo Tsubota; Cellular senescence promotes meibomian gland dysfunction (MGD) in a chronic graft-vs-host disease (cGVHD) mouse model. Invest. Ophthalmol. Vis. Sci. 2023;64(8):691.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Since aging is a well-known risk factor for MGD, and cellular senescence is accelerated in the lacrimal glands of a cGVHD mouse model, we hypothesized that cellular senescence might be related to MGD observed in cGVHD. Herein, we aimed to elucidate the relationship between cellular senescence and MGD in a cGVHD mouse model by using the selnolytic agent ABT-263.

Methods : Allogeneic bone marrow transplantation from B10.D2. to BALB/c mice was performed to produce mice with cGVHD. As a non-cGVHD control, syngeneic BMT was conducted by transplanting donor cells from BALB/c mice into BALB/c mice. The cGVHD mice were divided into 2 groups, which were treated with ABT-263 or vehicle by gavage once a day for 7 days from day 10 to 16 after BMT. We performed histological investigation, immunohistochemical examination, and quantitative PCR to elucidate the association between cellular senescence and MGD in the cGVHD mice at 4-week timepoints after BMT.

Results : Topographical results showed that meibomian gland (MG) area (%) in the cGVHD mice was significantly decreased than that in the syngeneic control mice, and the ABT-263-treated cGVHD mice retained significantly larger MG area (%) than the vehicle-treated cGVHD mice. Pathological analysis and immunohistochemical analysis using the inflammatory cell marker CD45 and the myofibroblast marker αSMA showed that inflammation and pathological fibrosis of eyelid tissue, including MGs, were significantly reduced in the ABT-263 group compared to the vehicle-treated group. Senescent cells secrete inflammatory cytokines and chemokines; this condition is termed the senescence-associated secretory phenotype (SASP). Compared with the syngeneic control mice, the expression of the DNA damage marker (γ-H2AX), senescent markers (p16 and p21), and SASP factors (IL-6, IL-8, IL1-β, and CXCL9) were significantly elevated in the eyelid of cGVHD mice. In addition, the expression of these cellular senescence-associated molecules in the eyelid in the ABT-263-treated cGVHD mice were significantly suppressed compared with those in the vehicle-treated cGVHD mice.

Conclusions : Cellular senescence and the expressions of SASP factors were promoted in the eyelid and MGs of the cGVHD mice, and the senolytic agent ABT-263 attenuated the severity of MGD. These findings suggested that cellular senescence might be effective targets for the treatment of MGD in cGVHD.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×